New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons
Oncology March 14,2024
Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons
Oncology March 14,2024
People who see climate change as a health threat show more interest in cancer screening

People who see climate change as a health threat show more interest in cancer screening

by Brigham and Women's HospitalCredit: Unsplash/CC0 Public DomainBrigham researchers' findings support developing public health interventions that incorporate components of environmental
Oncology March 14,2024
People who see climate change as a health threat show more interest in cancer screening

People who see climate change as a health threat show more interest in cancer screening

by Brigham and Women's HospitalCredit: Unsplash/CC0 Public DomainBrigham researchers' findings support developing public health interventions that incorporate components of environmental
Oncology March 14,2024
Dlung: A novel method for lung image registration

Dlung: A novel method for lung image registration

by Shanghai Jiao Tong University Journal CenterRespiratory motion modeling. (The cover picture of Volume 28 Issue 4, Shanghai Jiao Tong University (Science). This article was the cover article of that
Medical imageology March 14,2024
Dlung: A novel method for lung image registration

Dlung: A novel method for lung image registration

by Shanghai Jiao Tong University Journal CenterRespiratory motion modeling. (The cover picture of Volume 28 Issue 4, Shanghai Jiao Tong University (Science). This article was the cover article of that
Medical imageology March 14,2024
Type 2 diabetes linked to colorectal cancer risk in men

Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n
Oncology March 14,2024
Type 2 diabetes linked to colorectal cancer risk in men

Type 2 diabetes linked to colorectal cancer risk in men

(HealthDay)—Type 2 diabetes (T2D) is associated with an increased risk for colorectal cancer (CRC), with the association significant for men only, according to a study published online Nov. 7 in the&n
Oncology March 14,2024
3-D-written model to provide better understanding of cancer spread

3-D-written model to provide better understanding of cancer spread

by Kayla Wiles,Purdue UniversityThis diagram conceptualizes the 3-D jet writer a Purdue researcher is using to engineer a cancer microenvironment. Credit: Purdue University image/Luis SolorioPur
Oncology March 14,2024
3-D-written model to provide better understanding of cancer spread

3-D-written model to provide better understanding of cancer spread

by Kayla Wiles,Purdue UniversityThis diagram conceptualizes the 3-D jet writer a Purdue researcher is using to engineer a cancer microenvironment. Credit: Purdue University image/Luis SolorioPur
Oncology March 14,2024
Cervical cancer screening numbers drop off in women 45-65

Cervical cancer screening numbers drop off in women 45-65

by University of MichiganCredit: CC0 Public DomainCervical cancer is one of the most preventable types of cancer affecting women in the United States. That's because there are two good screen
Oncology March 14,2024
Cervical cancer screening numbers drop off in women 45-65

Cervical cancer screening numbers drop off in women 45-65

by University of MichiganCredit: CC0 Public DomainCervical cancer is one of the most preventable types of cancer affecting women in the United States. That's because there are two good screen
Oncology March 14,2024
Balance of 'stop' and 'go' signaling could be key to cancer immunotherapy response

Balance of 'stop' and 'go' signaling could be key to cancer immunotherapy response

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by ca
Oncology March 14,2024
Balance of 'stop' and 'go' signaling could be key to cancer immunotherapy response

Balance of 'stop' and 'go' signaling could be key to cancer immunotherapy response

by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA crucial signaling pathway that can tell the immune system to fight off cancer can also be co-opted by ca
Oncology March 14,2024
Twenty five years of learning to combat cervical cancer

Twenty five years of learning to combat cervical cancer

by National Centre for Biological SciencesGlobal cervical cancer statistics 2018: Estimates of incidence and mortality. Credit:A Cancer Journal for Clinicians(2018). Volume 68, Issue: 6, P
Oncology March 14,2024
Twenty five years of learning to combat cervical cancer

Twenty five years of learning to combat cervical cancer

by National Centre for Biological SciencesGlobal cervical cancer statistics 2018: Estimates of incidence and mortality. Credit:A Cancer Journal for Clinicians(2018). Volume 68, Issue: 6, P
Oncology March 14,2024
New AI algorithm identifies risk of falls and fracture for older women

New AI algorithm identifies risk of falls and fracture for older women

by Edith Cowan UniversityCredit: CC0 Public DomainA new automated machine-learning algorithm has been developed by researchers at Edith Cowan University (ECU). The algorithm accurately assesses a
Medical imageology March 14,2024
New AI algorithm identifies risk of falls and fracture for older women

New AI algorithm identifies risk of falls and fracture for older women

by Edith Cowan UniversityCredit: CC0 Public DomainA new automated machine-learning algorithm has been developed by researchers at Edith Cowan University (ECU). The algorithm accurately assesses a
Medical imageology March 14,2024
Novel PET tracer enhances lesion detection in medullary thyroid cancer, offers potential for targeted therapy

Novel PET tracer enhances lesion detection in medullary thyroid cancer, offers potential for targeted therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projections (left) and fused transaxial sections (right) of 46-y-old female MTC patient undergoing PET/CT 2 hours after intravenou
Medical imageology March 14,2024
Novel PET tracer enhances lesion detection in medullary thyroid cancer, offers potential for targeted therapy

Novel PET tracer enhances lesion detection in medullary thyroid cancer, offers potential for targeted therapy

by Society of Nuclear Medicine and Molecular ImagingMaximum-intensity projections (left) and fused transaxial sections (right) of 46-y-old female MTC patient undergoing PET/CT 2 hours after intravenou
Medical imageology March 14,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com